Disability and Disability-Adjusted Life Years: Not the Same

Mont D. Measuring health and disability. Lancet 2007;369:1658–63.

Murray CJ Acharya AK . Understanding DALYs (disability-adjusted life years). J Health Econ 1997;16:703–30.

Murray CJL Salomon JA Mathers CD . A critical examination of summary measures of population health. In: Murray CJL Salomon JA Mathers CD Lopez AD , editors. Summary measures of population health: Concepts, ethics, measurement, and applications. Geneva: World Health Organization; 2002. p. 13–40.

Murray CJL Lopez AD , editors. The global burden of disease: A comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. Cambridge (MA): Harvard University Press; 1996.

Lopez AD Mathers CD Ezzati M Jamison DT Murray CJL , editors. Global burden of disease and risk factors. Washington: World Bank; 2006.

Lopez AD Mathers CD Ezzati M Jamison DT Murray CJ . Global and regional burden of disease and risk factors, 2001: Systematic analysis of population health data. Lancet 2006;367:1747–57.

Melse JM Essink-Bot ML Kramers PG Hoeymans N. A national burden of disease calculation: Dutch disability-adjusted life-years. Dutch Burden of Disease Group. Am J Public Health 2000;90:1241–7.

Mathers CD Vos ET Stevenson CE Begg SJ . The burden of disease and injury in Australia. Bull World Health Organ 2001;79:1076–84.

Michaud CM McKenna MT Begg S Tomijima N Majmudar M Bulzacchelli MT , The burden of disease and injury in the United States, 1996. Popul Health Metr 2006;4:11.

Kominski GF Simon PA Ho A Luck J Lim YW Fielding JE . Assessing the burden of disease and injury in Los Angeles County using disability-adjusted life years. Public Health Rep 2002;117:185–91.

Cadilhac DA Carter RC Thrift AG Dewey HM . Why invest in a national public health program for stroke? An example using Australian data to estimate the potential benefits and cost implications. Health Policy 2007;83:287–94.

Gross CP Anderson GF Powe NR . The relation between funding by the National Institutes of Health and the burden of disease. N Engl J Med 1999;340:1881–7.

Lamarre-Cliché M Castilloux AM LeLorier J. Association between the burden of disease and research funding by the Medical Research Council of Canada and the National Institutes of Health. A cross-sectional study. Clin Invest Med 2001;24:83–9.

Aoun S Pennebaker D Pascal R. To what extent is health and medical research funding associated with the burden of disease in Australia? Aust N Z J Public Health 2004;28:80–6.

Curry CW De AK Ikeda RM Thacker SB . Health burden and funding at the Centers for Disease Control and Prevention. Am J Prev Med 2006;30:269–76.

Institute of Medicine; Committee to Evaluate Measures of Health Benefits for Environmental, Health, and Safety Regulation; Miller W Robinson LA Lawrence RS , editors. Valuing health for regulatory cost-effectiveness analysis. Washington: National Academies Press; 2006.

Schackman BR Neukermans CP Fontain SN Nolte C Joseph P Pape JW , Cost-effectiveness of rapid syphilis screening in prenatal HIV testing programs in Haiti. PLoS Med 2007;4:e183.

Sinha A Levine O Knoll MD Muhib F Lieu TA . Cost-effectiveness of pneumococcal conjugate vaccination in the prevention of child mortality: An international economic analysis. Lancet 2007;369:389–96.

Llanos A Hertrampf E Cortes F Pardo A Grosse SD Uauy R. Cost-effectiveness of a folic acid fortification program in Chile. Health Policy 2007;83:295–303.

Tan-Torres Edejer T Baltussen R Adam T Hutubessy R Acharya A Evans DB , editors. Making choices in health: WHO guide to cost-effectiveness analysis. Geneva: World Health Organization; 2003. Also available from: URL: http://www.who.int/choice/publications/p_2003_generalised_cea.pdf [cited 2006 Mar 15].

Mathers CD Vos T Lopez AD Salomon J Ezzati M , editors. National burden of disease studies: A practical guide. Edition 2.0. Geneva: World Health Organization; 2001. Also available from: URL: http://www.who.int/healthinfo/nationalburdenofdiseasemanual.pdf [cited 2006 Mar 15].

World Health Organization. International classification of functioning, disability and health (ICF) [cited 2008 Jul 2]. Available from: URL: http://www.who.int/classifications/icf/en.

Chamie M. What does morbidity have to do with disability? Disabil Rehabil 1995;17:323–37.

Groce NE Chamie M Me A. Measuring the quality of life: Rethinking the World Bank's disability adjusted life years. Int Rehab Rev 1999;49:12–5.

Jelsma J De Weerdt W De Cock P. Disability adjusted life years (DALYs) and rehabilitation. Disabil Rehabil 2002;24:378–82.

Fedeyko HJ Lollar DJ . Classifying disability data. A fresh, integrative perspective. In: Altman BM Barnartt SN Hendershot G Larson S , editors. Using survey data to study disability: Results from the National Health Interview Survey on Disability, volume 3. London: JAI Press; 2003. p. 55–72.

World Bank. World development report 1993: Investing in health. New York: Oxford University Press; 1993.

Jamison DT Mosley WH Measham AR Bobadilla JL , editors. Disease control priorities in developing countries. 2nd ed. New York: Oxford University Press; 1994.

Murray CJ . Quantifying the burden of disease: The technical basis for disability-adjusted life years. Bull World Health Organ 1994;72:429–45.

Nord E. My goodness—and yours: A history, and some possible futures, of DALY meanings and valuation procedures. In: Murray CJL Salomon JA Mathers CD Lopez AD , editors. Summary measures of population health: Concepts, ethics, measurement and applications. Geneva: World Health Organization; 2002. p.139–46.

Arnesen T Nord E. The value of DALY life: Problems with ethics and validity of disability adjusted life years. BMJ 1999;319:1423–5.

Mansley EC Elbasha EH . Preferences and person trade-offs: Forcing consistency or inconsistency in health-related quality of life measures? Health Econ 2003;12:187–98.

Sassi F. Calculating QALYs, comparing QALY and DALY calculations. Health Policy Plan 2006;21:402–8.

Schwarzinger M Stouthard ME Burstrom K Nord E. Cross-national agreement on disability weights: The European Disability Weights Project. Popul Health Metr 2003;1:9.

Schwarzinger M Lanoe JL Nord E Durand-Zaleski I. Lack of multiplicative transitivity in person trade-off responses. Health Econ 2004;13:171–81.

Nord E. The desirability of a condition versus the well-being and worth of a person. Health Econ 2001;10:579–81.

Rock M. Discounted lives? Weighing disability when measuring health and ruling on “compassionate” murder. Soc Sci Med 2000;51: 407–17.

Fox-Rushby JA . Disability adjusted life years (DALYS) for decision-making? An overview of the literature. London: Office of Health Economics; 2002.

McKenna M Marks J. Commentary on the uses of summary measures of population health. In: Murray CJL Salomon JA Mathers CD Lopez AD , editors. Summary measures of population health: Concepts, ethics, measurement and applications. Geneva: World Health Organization; 2002. p. 67–74.

Murray CJ Lopez AD . Quantifying disability: Data, methods and results. Bull World Health Organ 1994;72:481–94.

Mont D Loeb M. Beyond DALYs: Developing indicators to assess the impact of public health interventions on the lives of people with disabilities. SP Discussion Paper No. 0815. Washington: The World Bank; 2008.

Gilbert D. Stumbling on happiness. New York: Knopf; 2006.

Schwartz CE Andresen EM Nosek MA Krahn GL . Response shift theory: Important implications for measuring quality of life in people with disability. Arch Phys Med Rehabil 2007;88:529–36.

Andresen EM Vahle VJ Lollar D. Proxy reliability: Health-related quality of life (HRQoL) measures for people with disability. Qual Life Res 2001;10:609–19.

Hays RD Hahn H Marshall G. Use of the SF-36 and other health-related quality of life measures to assess persons with disabilities. Arch Phys Med Rehabil 2002;83(12 Suppl 2):S4–9.

Sanders SJ . Depression cited as the top cause of medical disability. AMNews 2007 Apr 2 [cited 2008 Sep 28]. Available from: URL: http://www.ama-assn.org/amednews/2007/04/02/hlsb0402.htm.

Thacker SB Stroup DF Carande-Kulis V Marks JS Roy K Gerberding JL . Measuring the public's health. Public Health Rep 2006;121: 14–22.

Prevalence of disabilities and associated health conditions among adults—United States, 1999. MMWR Morb Mortal Wkly Rep 2001; 50(7):120–5.

Ozminkowski RJ Burton WN Goetzel RZ Maclean R Wang S. The impact of rheumatoid arthritis on medical expenditures, absenteeism, and short-term disability benefits. J Occup Environ Med 2006;48:135–48.

Arnesen T Kapiriri L. Can the value choices in DALYs influence global priority-setting? Health Policy 2004;70:137–49.

Stouthard MEA Essink-Bot ML Bonsel GJ , On behalf of the Dutch Disability Weights Group. Disability weights for diseases: A modified protocol and results for a Western European region. Eur J Public Health 2000;10:24–30.

Mathers C Vos T Stevenson C. The burden of disease and injury in Australia. Australian Institute of Health and Welfare. Canberra (Australia): AIHW; 1999. Also available from: URL: http://www.aihw.gov.au/publications/phe/bdia/bdia.pdf [cited 2008 Jul 1].